TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4925166
log Bayes Factor = 0.164964
Chromosome 17   position 18,210,810  (GRCh37) Explore rs4925166 on Ensembl!
Variant rs4925166 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C71 Malignant neoplasm of brain
0.000 0.828 0.172
C71.9 Brain, unspecified
0.000 0.829 0.171
C71.3 Parietal lobe
0.000 0.843 0.157
C71.1 Frontal lobe
0.000 0.846 0.154
I42.9 Cardiomyopathy, unspecified
0.000 0.849 0.151
C71.0 Cerebrum, except lobes and ventricles
0.000 0.850 0.150
C71.8 Overlapping lesion of brain
0.000 0.859 0.141
C71.6 Cerebellum
0.000 0.865 0.135
C71.2 Temporal lobe
0.000 0.867 0.133
C71.5 Cerebral ventricle
0.000 0.870 0.130
C71.7 Brain stem
0.000 0.872 0.128
C71.4 Occipital lobe
0.000 0.881 0.119
E05.0 Thyrotoxicosis with diffuse goitre
0.091 0.909 0.000
I42 Cardiomyopathy
0.000 0.917 0.083
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.000 0.923 0.077
I42.2 Other hypertrophic cardiomyopathy
0.000 0.928 0.072
I42.6 Alcoholic cardiomyopathy
0.000 0.930 0.070
G62.9 Polyneuropathy, unspecified
0.000 0.935 0.065
I42.7 Cardiomyopathy due to drugs and other external agents
0.000 0.935 0.064
I42.5 Other restrictive cardiomyopathy
0.000 0.940 0.059
I42.3 Endomyocardial (eosinophilic) disease
0.000 0.940 0.059
C69 Malignant neoplasm of eye and adnexa
0.000 0.941 0.059
C70 Malignant neoplasm of meninges
0.000 0.943 0.057
I42.0 Dilated cardiomyopathy
0.000 0.946 0.054
I42.4 Endocardial fibroelastosis
0.000 0.946 0.054
C69.3 Choroid
0.000 0.947 0.053
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.000 0.947 0.053
G62 Other polyneuropathies
0.000 0.948 0.052
I42.8 Other cardiomyopathies
0.000 0.949 0.051
I42.1 Obstructive hypertrophic cardiomyopathy
0.000 0.952 0.048
C69.2 Retina
0.000 0.953 0.047
G62.8 Other specified polyneuropathies
0.000 0.955 0.045
C70.0 Cerebral meninges
0.000 0.957 0.043
G62.1 Alcoholic polyneuropathy
0.000 0.957 0.043
C69.8 Overlapping lesion of eye and adnexa
0.000 0.958 0.042
C69.5 Lachrymal gland and duct
0.000 0.958 0.042
C69.1 Cornea
0.000 0.958 0.042
C70.9 Meninges, unspecified
0.000 0.959 0.041
C70.1 Spinal meninges
0.000 0.959 0.041
G62.0 Drug-induced polyneuropathy
0.000 0.960 0.040
C72.9 Central nervous system, unspecified
0.000 0.962 0.038
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.000 0.962 0.038
C72.5 Other and unspecified cranial nerves
0.000 0.962 0.038
C72.4 Acoustic nerve
0.000 0.962 0.038
C72.3 Optic nerve
0.000 0.962 0.038
C72.2 Olfactory nerve
0.000 0.962 0.038
C72.1 Cauda equina
0.000 0.962 0.038
C69.4 Ciliary body
0.000 0.962 0.038
G62.2 Polyneuropathy due to other toxic agents
0.000 0.962 0.037
C69.6 Orbit
0.000 0.962 0.037
C69.0 Conjunctiva
0.000 0.963 0.036
C72.0 Spinal cord
0.000 0.964 0.035
C69.9 Eye, unspecified
0.000 0.964 0.035
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.968 0.032
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.970 0.029
Y45.2 Propionic acid derivatives
0.000 0.973 0.027
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.974 0.026
Y45.1 Salicylates
0.000 0.975 0.025
Y45.8 Other analgesics and antipyretics
0.000 0.975 0.025
Y45.5 4-Aminophenol derivatives
0.000 0.976 0.023
E05 Thyrotoxicosis [hyperthyroidism]
0.023 0.977 0.000
Y45.4 Antirheumatics
0.000 0.978 0.022
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.019 0.981 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.018 0.982 0.000
E05.5 Thyroid crisis or storm
0.016 0.983 0.000
E05.4 Thyrotoxicosis factitia
0.016 0.983 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.016 0.983 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.016 0.983 0.000
E05.8 Other thyrotoxicosis
0.016 0.984 0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
0.000 0.985 0.015
Y51 Drugs primarily affecting the autonomic nervous system
0.013 0.986 0.001
Y45.0 Opioids and related analgesics
0.000 0.986 0.013
G63 Polyneuropathy in diseases classified elsewhere
0.000 0.987 0.013
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.011 0.987 0.001
Y43.3 Other antineoplastic drugs
0.000 0.988 0.012
Y53 Agents primarily affecting the gastro-intestinal system
0.012 0.988 0.000
G63.2 Diabetic polyneuropathy
0.000 0.988 0.012
Y53.1 Other antacids and anti-gastric-secretion drugs
0.012 0.988 0.000
Y40 Systemic antibiotics
0.011 0.989 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.011 0.989 0.000
J35.1 Hypertrophy of tonsils
0.000 0.989 0.011
Y42.7 Androgens and anabolic congeners
0.011 0.989 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.010 0.989 0.001
Y46 Antiepileptics and anti-Parkinsonism drugs
0.010 0.989 0.001
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.010 0.989 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.010 0.989 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.010 0.990 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.010 0.990 0.001
G60 Hereditary and idiopathic neuropathy
0.000 0.990 0.010
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.010 0.990 0.001
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.010 0.990 0.001
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.010 0.990 0.001
Y51.1 Other parasympathomimetics [cholinergics]
0.010 0.990 0.001
Y51.0 Anticholinesterase agents
0.010 0.990 0.001
H44.2 Degenerative myopia
0.000 0.990 0.010
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.009 0.990 0.001
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.010 0.990 0.001
Y40.3 Macrolides
0.010 0.990 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.009 0.990 0.001
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.010 0.990 0.000
G64 Other disorders of peripheral nervous system
0.000 0.990 0.010
S52.00 Fracture of upper end of ulna (closed)
0.010 0.990 0.000
Y57 Other and unspecified drugs and medicaments
0.010 0.990 0.000
Y46.4 Iminostilbenes
0.010 0.990 0.000
Y49.5 Other antipsychotics and neuroleptics
0.010 0.990 0.000
G63.8 Polyneuropathy in other diseases classified elsewhere
0.000 0.990 0.010
G63.6 Polyneuropathy in other musculoskeletal disorders
0.000 0.990 0.010
G63.5 Polyneuropathy in systemic connective tissue disorders
0.000 0.990 0.010
G63.4 Polyneuropathy in nutritional deficiency
0.000 0.990 0.010
G63.3 Polyneuropathy in other endocrine and metabolic diseases
0.000 0.990 0.010
G63.1 Polyneuropathy in neoplastic disease
0.000 0.990 0.010
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere
0.000 0.990 0.010
J35 Chronic diseases of tonsils and adenoids
0.000 0.990 0.010
Y40.8 Other systemic antibiotics
0.010 0.990 0.000
Y40.7 Antifungal antibiotics, systemically used
0.010 0.990 0.000
Y53.2 Stimulant laxatives
0.009 0.990 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.008 0.991 0.001
Y53.6 Antidiarrhoeal drugs
0.009 0.991 0.000
Y40.5 Aminoglycosides
0.009 0.991 0.000
J35.2 Hypertrophy of adenoids
0.000 0.991 0.009
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.009 0.991 0.000
J35.8 Other chronic diseases of tonsils and adenoids
0.000 0.991 0.009
Y40.6 Rifamycins
0.009 0.991 0.000
Y42.9 Other and unspecified hormone antagonists
0.009 0.991 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.008 0.991 0.000
Y53.7 Emetics
0.008 0.991 0.000
Y53.5 Digestants
0.008 0.991 0.000
Y53.0 Histamine H2-receptor antagonists
0.008 0.991 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.009 0.991 0.000
Y59 Other and unspecified vaccines and biological substances
0.008 0.991 0.001
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.008 0.991 0.000
Y53.3 Saline and osmotic laxatives
0.008 0.991 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.008 0.991 0.000
Y42.5 Other oestrogens and progestogens
0.009 0.991 0.000
Y48 Anaesthetics and therapeutic gases
0.008 0.991 0.001
J35.9 Chronic disease of tonsils and adenoids, unspecified
0.000 0.992 0.008
Y40.2 Chloramphenicol group
0.008 0.992 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.008 0.992 0.001
Y58 Bacterial vaccines
0.007 0.992 0.001
Y49.8 Other psychotropic drugs, not elsewhere classified
0.008 0.992 0.001
Y41.1 Antimycobacterial drugs
0.008 0.992 0.000
Y42.2 Antithyroid drugs
0.008 0.992 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.008 0.992 0.001
Y47 Sedatives, hypnotics and antianxiety drugs
0.007 0.992 0.001
Y40.9 Systemic antibiotic, unspecified
0.008 0.992 0.000
G60.0 Hereditary motor and sensory neuropathy
0.000 0.992 0.008
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.008 0.992 0.000
Y55.4 Expectorants
0.008 0.992 0.001
Y42.4 Oral contraceptives
0.008 0.992 0.000
Y49.9 Psychotropic drug, unspecified
0.007 0.992 0.001
Y49.7 Psychostimulants with abuse potential
0.007 0.992 0.001
Y49.6 Psychodysleptics [hallucinogens]
0.007 0.992 0.001
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.007 0.992 0.001
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.007 0.992 0.001
Y57.8 Other drugs and medicaments
0.008 0.992 0.000
Y40.0 Penicillins
0.008 0.992 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.007 0.992 0.001
I77.1 Stricture of artery
0.008 0.992 0.000
Y46.7 Anti-Parkinsonism drugs
0.007 0.992 0.001
Y46.8 Antispasticity drugs
0.007 0.992 0.001
Y46.3 Deoxybarbiturates
0.007 0.992 0.001
Y46.1 Oxazolidinediones
0.007 0.992 0.001
Y46.0 Succinimides
0.007 0.992 0.001
Y53.4 Other laxatives
0.007 0.992 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.007 0.992 0.000
Y41.4 Anthelminthics
0.007 0.992 0.000
Y41.3 Other antiprotozoal drugs
0.007 0.992 0.000
Y43 Primarily systemic agents
0.002 0.992 0.006
Y41.5 Antiviral drugs
0.007 0.992 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.008 0.992 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.007 0.992 0.001
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.007 0.992 0.001
Y46.6 Other and unspecified antiepileptics
0.007 0.992 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.008 0.992 0.000
G60.9 Hereditary and idiopathic neuropathy, unspecified
0.000 0.992 0.008
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.007 0.992 0.001
Y55.5 Anticommon cold drugs
0.007 0.992 0.001
Y55.3 Antitussives
0.007 0.992 0.001
Y55.2 Other and unspecified agents primarily acting on muscles
0.007 0.992 0.001
Y55.0 Oxytocic drugs
0.007 0.992 0.001
G60.3 Idiopathic progressive neuropathy
0.000 0.992 0.007
G60.2 Neuropathy in association with hereditary ataxia
0.000 0.992 0.007
G60.1 Refsum's disease
0.000 0.992 0.007
Y46.5 Valproic acid
0.007 0.992 0.001
Y56.9 Topical agent, unspecified
0.007 0.992 0.001
Y56.8 Other topical agents
0.007 0.992 0.001
Y56.7 Dental drugs, topically applied
0.007 0.992 0.001
Y56.6 Otorhinolaryngological drugs and preparations
0.007 0.992 0.001
Y56.5 Ophthalmological drugs and preparations
0.007 0.992 0.001
Y56.2 Local astringents and local detergents
0.007 0.992 0.001
Y56.1 Antipruritics
0.007 0.992 0.001
R56.8 Other and unspecified convulsions
0.000 0.992 0.008
Y57.6 Other diagnostic agents
0.007 0.992 0.000
Y46.2 Hydantoin derivatives
0.007 0.993 0.001
Y40.4 Tetracyclines
0.007 0.993 0.000
Y57.9 Drug or medicament, unspecified
0.007 0.993 0.000
Y44 Agents primarily affecting blood constituents
0.007 0.993 0.001
Y41.0 Sulphonamides
0.007 0.993 0.000
Y42.1 Thyroid hormones and substitutes
0.007 0.993 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.007 0.993 0.000
Y57.7 Vitamins, not elsewhere classified
0.007 0.993 0.000
Y57.4 Pharmaceutical excipients
0.007 0.993 0.000
Y57.3 Alcohol deterrents
0.007 0.993 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.007 0.993 0.000
Y57.1 Lipotropic drugs
0.007 0.993 0.000
Y57.0 Appetite depressants [anorectics]
0.007 0.993 0.000
Y57.5 X-ray contrast media
0.007 0.993 0.000
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids
0.000 0.993 0.007
Y50.9 Central nervous system stimulant, unspecified
0.006 0.993 0.001
Y50.8 Other central nervous system stimulants
0.006 0.993 0.001
Y50.2 Methylxanthines, not elsewhere classified
0.006 0.993 0.001
Y50.1 Opioid receptor antagonists
0.006 0.993 0.001
Y50.0 Analeptics
0.006 0.993 0.001
Y56.3 Emollients, demulcents and protectants
0.006 0.993 0.001
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.006 0.993 0.001
Y59.9 Vaccine or biological substance, unspecified
0.006 0.993 0.001
Y59.8 Other specified vaccines and biological substances
0.006 0.993 0.001
Y59.2 Protozoal vaccines
0.006 0.993 0.001
Y59.1 Rickettsial vaccines
0.006 0.993 0.001
Y59.0 Viral vaccines
0.006 0.993 0.001
Y48.5 Therapeutic gases
0.006 0.994 0.001
Y48.2 Other and unspecified general anaesthetics
0.006 0.994 0.001
Y48.1 Parenteral anaesthetics
0.006 0.994 0.001
Y48.0 Inhaled anaesthetics
0.006 0.994 0.001
Y58.9 Other and unspecified bacterial vaccines
0.005 0.994 0.001
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.005 0.994 0.001
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.005 0.994 0.001
Y58.5 Diphtheria vaccine
0.005 0.994 0.001
Y58.4 Tetanus vaccine
0.005 0.994 0.001
Y58.3 Plague vaccine
0.005 0.994 0.001
Y58.2 Cholera vaccine
0.005 0.994 0.001
Y58.1 Typhoid and paratyphoid vaccine
0.005 0.994 0.001
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.005 0.994 0.001
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.005 0.994 0.001
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.005 0.994 0.001
Y47.4 Bromine compounds
0.005 0.994 0.001
Y47.3 Paraldehyde
0.005 0.994 0.001
Y47.2 Chloral derivatives
0.005 0.994 0.001
Y47.0 Barbiturates, not elsewhere classified
0.005 0.994 0.001
Y59.3 Immunoglobulin
0.005 0.994 0.001
S52.0 Fracture of upper end of ulna
0.006 0.994 0.000
Y48.4 Anaesthetic, unspecified
0.005 0.994 0.001
G60.8 Other hereditary and idiopathic neuropathies
0.000 0.994 0.006
Y43.0 Antiallergic and antiemetic drugs
0.001 0.994 0.005
I47.1 Supraventricular tachycardia
0.000 0.994 0.006
Y43.9 Primarily systemic agent, unspecified
0.002 0.994 0.004
Y43.8 Other primarily systemic agents, not elsewhere classified
0.002 0.994 0.004
Y43.6 Enzymes, not elsewhere classified
0.002 0.994 0.004
Y43.5 Acidifying and alkalising agents
0.002 0.994 0.004
Y44.6 Natural blood and blood products
0.005 0.994 0.001
Y48.3 Local anaesthetics
0.005 0.994 0.001
M43.16 Spondylolisthesis (Lumbar region)
0.006 0.994 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.005 0.994 0.001
Y49.2 Other and unspecified antidepressants
0.005 0.994 0.001
Z53.1 Procedure not carried out because of patient's decision for reasons of belief or group pressure
0.006 0.994 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.994 0.001
Y54.8 Agents affecting uric acid metabolism
0.005 0.994 0.001
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.005 0.994 0.001
Y44.9 Other and unspecified agents affecting blood constituents
0.005 0.994 0.001
Y44.7 Plasma substitutes
0.005 0.994 0.001
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.005 0.994 0.001
G61 Inflammatory polyneuropathy
0.000 0.994 0.005
M10.97 Gout, unspecified (Ankle and foot)
0.000 0.995 0.005
Y43.2 Antineoplastic natural products
0.002 0.995 0.003
Y43.1 Antineoplastic antimetabolites
0.001 0.995 0.004
Y58.0 BCG vaccine
0.004 0.995 0.001
S52.01 Fracture of upper end of ulna (open)
0.005 0.995 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.005 0.995 0.001
Y47.1 Benzodiazepines
0.004 0.995 0.001
Y43.4 Immunosuppressive agents
0.001 0.995 0.004
Y54.9 Mineral salts, not elsewhere classified
0.004 0.995 0.001
Y54.6 Electrolytic, caloric and water-balance agents
0.004 0.995 0.001
Y54.2 Carbonic-anhydrase inhibitors
0.004 0.995 0.001
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.005 0.995 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.995 0.005
Y54.0 Mineralocorticoids
0.004 0.995 0.001
G25.8 Other specified extrapyramidal and movement disorders
0.005 0.995 0.000
Y44.5 Thrombolytic drugs
0.004 0.995 0.001
M43.1 Spondylolisthesis
0.005 0.995 0.000
Y54.7 Agents affecting calcification
0.004 0.995 0.001
Y54.4 Loop [high-ceiling] diuretics
0.004 0.995 0.001
H44 Disorders of globe
0.000 0.995 0.005
J35.0 Chronic tonsillitis
0.000 0.995 0.005
M43.19 Spondylolisthesis (Site unspecified)
0.004 0.996 0.000
Y52 Agents primarily affecting the cardiovascular system
0.002 0.996 0.003
J18.9 Pneumonia, unspecified
0.004 0.996 0.000
G61.1 Serum neuropathy
0.000 0.996 0.004
Y54.5 Other diuretics
0.003 0.996 0.001
G25 Other extrapyramidal and movement disorders
0.004 0.996 0.000
H44.1 Other endophthalmitis
0.000 0.996 0.004
F20.0 Paranoid schizophrenia
0.000 0.996 0.004
M43.17 Spondylolisthesis (Lumbosacral region)
0.004 0.996 0.000
M43.10 Spondylolisthesis (Multiple sites in spine)
0.004 0.996 0.000
I81 Portal vein thrombosis
0.000 0.996 0.004
H44.5 Degenerated conditions of globe
0.000 0.996 0.004
H44.4 Hypotony of eye
0.000 0.996 0.004
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.996 0.004
H44.7 Retained (old) intraocular foreign body, nonmagnetic
0.000 0.996 0.004
G25.1 Drug-induced tremor
0.004 0.996 0.000
J06.9 Acute upper respiratory infection, unspecified
0.000 0.996 0.004
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M43.15 Spondylolisthesis (Thoracolumbar region)
0.004 0.996 0.000
M43.14 Spondylolisthesis (Thoracic region)
0.004 0.996 0.000
M43.13 Spondylolisthesis (Cervicothoracic region)
0.004 0.996 0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.004 0.996 0.000
I49.8 Other specified cardiac arrhythmias
0.004 0.996 0.000
R56 Convulsions, not elsewhere classified
0.000 0.996 0.004
G25.9 Extrapyramidal and movement disorder, unspecified
0.004 0.996 0.000
H44.6 Retained (old) intraocular foreign body, magnetic
0.000 0.996 0.003
H44.3 Other degenerative disorders of globe
0.000 0.996 0.003
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.001 0.996 0.003
G61.8 Other inflammatory polyneuropathies
0.000 0.996 0.003
G25.2 Other specified forms of tremor
0.003 0.996 0.000
G25.3 Myoclonus
0.003 0.997 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.001 0.997 0.002
Y52.7 Peripheral vasodilators
0.001 0.997 0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.001 0.997 0.002
G25.5 Other chorea
0.003 0.997 0.000
Y54.3 Benzothiadiazine derivatives
0.002 0.997 0.001
M43.12 Spondylolisthesis (Cervical region)
0.003 0.997 0.000
C44.2 Skin of ear and external auricular canal
0.003 0.997 0.000
M46.46 Discitis, unspecified (Lumbar region)
0.000 0.997 0.003
G25.6 Drug-induced tics and other tics of organic origin
0.003 0.997 0.000
G25.4 Drug-induced chorea
0.003 0.997 0.000
H44.8 Other disorders of globe
0.000 0.997 0.003
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.001 0.997 0.002
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.000 0.997 0.003
G61.9 Inflammatory polyneuropathy, unspecified
0.001 0.997 0.003
F40.2 Specific (isolated) phobias
0.003 0.997 0.000
M43 Other deforming dorsopathies
0.003 0.997 0.000
R56.0 Febrile convulsions
0.000 0.997 0.003
Y52.1 Calcium-channel blockers
0.001 0.997 0.002
W18.5 Trade and service area
0.003 0.997 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.997 0.003
C32.1 Supraglottis
0.000 0.997 0.003
W19.3 Sports and athletics area
0.000 0.997 0.003
F40.0 Agoraphobia
0.003 0.997 0.000
H44.9 Disorder of globe, unspecified
0.000 0.997 0.003
K09.0 Developmental odontogenic cysts
0.003 0.997 0.000
G61.0 Guillain-Barre syndrome
0.000 0.997 0.003
J18 Pneumonia, organism unspecified
0.003 0.997 0.000
F20.9 Schizophrenia, unspecified
0.000 0.997 0.003
Y44.2 Anticoagulants
0.002 0.997 0.001
S52.10 Fracture of upper end of radius (closed)
0.003 0.997 0.000
F20 Schizophrenia
0.000 0.997 0.003
G25.0 Essential tremor
0.003 0.997 0.000
J15 Bacterial pneumonia, not elsewhere classified
0.003 0.997 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.002 0.997 0.001
Y52.4 Angiotensin-converting-enzyme inhibitors
0.001 0.997 0.002
J09-J18 Influenza and pneumonia
0.003 0.997 0.000
J10 Influenza due to identified influenza virus
0.003 0.997 0.000
M43.6 Torticollis
0.002 0.997 0.000
M43.2 Other fusion of spine
0.002 0.997 0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified
0.003 0.997 0.000
K31.9 Disease of stomach and duodenum, unspecified
0.003 0.997 0.000
M43.8 Other specified deforming dorsopathies
0.002 0.997 0.000
M43.5 Other recurrent vertebral subluxation
0.002 0.997 0.000
M43.4 Other recurrent atlantoaxial subluxation
0.002 0.997 0.000
M43.3 Recurrent atlantoaxial subluxation with myelopathy
0.002 0.997 0.000
J15.1 Pneumonia due to Pseudomonas
0.002 0.997 0.000
J15.0 Pneumonia due to Klebsiella pneumoniae
0.002 0.997 0.000
M43.9 Deforming dorsopathy, unspecified
0.002 0.998 0.000
J15.9 Bacterial pneumonia, unspecified
0.002 0.998 0.000
J13 Pneumonia due to Streptococcus pneumoniae
0.002 0.998 0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae
0.002 0.998 0.000
W19.4 Street and highway
0.002 0.998 0.000
F40 Phobic anxiety disorders
0.002 0.998 0.000
M00.96 Pyogenic arthritis, unspecified (Lower leg)
0.002 0.998 0.000
J15.2 Pneumonia due to staphylococcus
0.002 0.998 0.000
M40 Kyphosis and lordosis
0.002 0.998 0.000
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)
0.000 0.998 0.002
J18.2 Hypostatic pneumonia, unspecified
0.002 0.998 0.000
J09 Influenza due to certain identified influenza virus
0.002 0.998 0.000
M40.5 Lordosis, unspecified
0.002 0.998 0.000
F20.5 Residual schizophrenia
0.000 0.998 0.002
F20.2 Catatonic schizophrenia
0.000 0.998 0.002
M40.56 Lordosis, unspecified (Lumbar region)
0.002 0.998 0.000
E23.2 Diabetes insipidus
0.002 0.998 0.000
F20.6 Simple schizophrenia
0.000 0.998 0.002
F20.4 Postschizophrenic depression
0.000 0.998 0.002
F20.3 Undifferentiated schizophrenia
0.000 0.998 0.002
F20.1 Hebephrenic schizophrenia
0.000 0.998 0.002
N18.5 Chronic kidney disease, stage 5
0.002 0.998 0.000
C44.0 Skin of lip
0.002 0.998 0.000
M40.2 Other and unspecified kyphosis
0.002 0.998 0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified
0.002 0.998 0.000
J11 Influenza, virus not identified
0.002 0.998 0.000
J15.3 Pneumonia due to streptococcus, group B
0.002 0.998 0.000
K09.8 Other cysts of oral region, not elsewhere classified
0.002 0.998 0.000
C02.1 Border of tongue
0.002 0.998 0.000
J10.0 Influenza with pneumonia, influenza virus identified
0.002 0.998 0.000
J15.8 Other bacterial pneumonia
0.002 0.998 0.000
M43.62 Torticollis-Cervical
0.002 0.998 0.000
T02.40 Fractures involving multiple regions of both upper limbs (closed)
0.002 0.998 0.000
M43.27 Other fusion of spine (Lumbosacral region)
0.002 0.998 0.000
M43.22 Other fusion of spine (Cervical region)
0.002 0.998 0.000
M43.86 Other specified deforming dorsopathies (Lumbar region)
0.002 0.998 0.000
H44.0 Purulent endophthalmitis
0.000 0.998 0.002
N18.2 Chronic kidney disease, stage 2
0.002 0.998 0.000
Z75.1 Person awaiting admission to adequate facility elsewhere
0.002 0.998 0.000
M43.28 Other fusion of spine (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M43.26 Other fusion of spine (Lumbar region)
0.002 0.998 0.000
M43.25 Other fusion of spine (Thoracolumbar region)
0.002 0.998 0.000
M43.24 Other fusion of spine (Thoracic region)
0.002 0.998 0.000
M43.23 Other fusion of spine (Cervicothoracic region)
0.002 0.998 0.000
M43.21 Other fusion of spine (Occipito-atlanto-axial region)
0.002 0.998 0.000
M43.20 Other fusion of spine (Multiple sites in spine)
0.002 0.998 0.000
J10.8 Influenza with other manifestations, influenza virus identified
0.002 0.998 0.000
J18.8 Other pneumonia, organism unspecified
0.002 0.998 0.000
N48.8 Other specified disorders of penis
0.002 0.998 0.000
M40.22 Other and unspecified kyphosis (Cervical region)
0.002 0.998 0.000
M43.29 Other fusion of spine (Site unspecified)
0.002 0.998 0.000
M43.68 Torticollis-Sacral/sacrococ
0.002 0.998 0.000
M43.67 Torticollis-Lumbosacral
0.002 0.998 0.000
M43.66 Torticollis-Lumbar
0.002 0.998 0.000
M43.65 Torticollis-Thoracolumbar
0.002 0.998 0.000
M43.64 Torticollis-Thoracic
0.002 0.998 0.000
M43.63 Torticollis-Cervicothoracic
0.002 0.998 0.000
M43.61 Torticollis-Occipit-atl-axl
0.002 0.998 0.000
M43.60 Torticollis-Mult site
0.002 0.998 0.000
C44.6 Skin of upper limb, including shoulder
0.002 0.998 0.000
J12 Viral pneumonia, not elsewhere classified
0.002 0.998 0.000
M43.69 Torticollis-Site unspe
0.002 0.998 0.000
M43.89 Other specified deforming dorsopathies (Site unspecified)
0.002 0.998 0.000
M43.88 Other specified deforming dorsopathies (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M43.87 Other specified deforming dorsopathies (Lumbosacral region)
0.002 0.998 0.000
M43.85 Other specified deforming dorsopathies (Thoracolumbar region)
0.002 0.998 0.000
M43.84 Other specified deforming dorsopathies (Thoracic region)
0.002 0.998 0.000
M43.83 Other specified deforming dorsopathies (Cervicothoracic region)
0.002 0.998 0.000
M43.82 Other specified deforming dorsopathies (Cervical region)
0.002 0.998 0.000
M43.81 Other specified deforming dorsopathies (Occipito-atlanto-axial region)
0.002 0.998 0.000
M43.80 Other specified deforming dorsopathies (Multiple sites in spine)
0.002 0.998 0.000
M46.4 Discitis, unspecified
0.000 0.998 0.002
M43.39 Recurrent atlantoaxial subluxation with myelopathy (Site unspecified)
0.002 0.998 0.000
M43.38 Recurrent atlantoaxial subluxation with myelopathy (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M43.37 Recurrent atlantoaxial subluxation with myelopathy (Lumbosacral region)
0.002 0.998 0.000
M43.36 Recurrent atlantoaxial subluxation with myelopathy (Lumbar region)
0.002 0.998 0.000
M43.35 Recurrent atlantoaxial subluxation with myelopathy (Thoracolumbar region)
0.002 0.998 0.000
M43.34 Recurrent atlantoaxial subluxation with myelopathy (Thoracic region)
0.002 0.998 0.000
M43.33 Recurrent atlantoaxial subluxation with myelopathy (Cervicothoracic region)
0.002 0.998 0.000
M43.32 Recurrent atlantoaxial subluxation with myelopathy (Cervical region)
0.002 0.998 0.000
M43.31 Recurrent atlantoaxial subluxation with myelopathy (Occipito-atlanto-axial region)
0.002 0.998 0.000
M43.30 Recurrent atlantoaxial subluxation with myelopathy (Multiple sites in spine)
0.002 0.998 0.000
M43.49 Other recurrent atlantoaxial subluxation-Site unspe
0.002 0.998 0.000
M43.48 Other recurrent atlantoaxial subluxation-Sacral/sacrococ
0.002 0.998 0.000
M43.47 Other recurrent atlantoaxial subluxation-Lumbosacral
0.002 0.998 0.000
M43.46 Other recurrent atlantoaxial subluxation-Lumbar
0.002 0.998 0.000
M43.45 Other recurrent atlantoaxial subluxation-Thoracolumbar
0.002 0.998 0.000
M43.44 Other recurrent atlantoaxial subluxation-Thoracic
0.002 0.998 0.000
M43.43 Other recurrent atlantoaxial subluxation-Cervicothoracic
0.002 0.998 0.000
M43.42 Other recurrent atlantoaxial subluxation-Cervical
0.002 0.998 0.000
M43.41 Other recurrent atlantoaxial subluxation-Occipit-atl-axl
0.002 0.998 0.000
M43.40 Other recurrent atlantoaxial subluxation-Mult site
0.002 0.998 0.000
M43.59 Other recurrent vertebral subluxation (Site unspecified)
0.002 0.998 0.000
M43.58 Other recurrent vertebral subluxation (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M43.57 Other recurrent vertebral subluxation (Lumbosacral region)
0.002 0.998 0.000
M43.56 Other recurrent vertebral subluxation (Lumbar region)
0.002 0.998 0.000
M43.55 Other recurrent vertebral subluxation (Thoracolumbar region)
0.002 0.998 0.000
M43.54 Other recurrent vertebral subluxation (Thoracic region)
0.002 0.998 0.000
M43.53 Other recurrent vertebral subluxation (Cervicothoracic region)
0.002 0.998 0.000
M43.52 Other recurrent vertebral subluxation (Cervical region)
0.002 0.998 0.000
M43.51 Other recurrent vertebral subluxation-Occipit-atl-axl
0.002 0.998 0.000
M43.50 Other recurrent vertebral subluxation (Multiple sites in spine)
0.002 0.998 0.000
M40.1 Other secondary kyphosis
0.002 0.998 0.000
S52.1 Fracture of upper end of radius
0.002 0.998 0.000
E24.0 Pituitary-dependent Cushing's disease
0.002 0.998 0.000
J15.5 Pneumonia due to Escherichia coli
0.002 0.998 0.000
M40-M43 Deforming dorsopathies
0.002 0.998 0.000
M43.98 Deforming dorsopathy, unspecified (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M43.97 Deforming dorsopathy, unspecified (Lumbosacral region)
0.002 0.998 0.000
M43.96 Deforming dorsopathy, unspecified (Lumbar region)
0.002 0.998 0.000
M43.95 Deforming dorsopathy, unspecified (Thoracolumbar region)
0.002 0.998 0.000
M43.94 Deforming dorsopathy, unspecified (Thoracic region)
0.002 0.998 0.000
M43.93 Deforming dorsopathy, unspecified (Cervicothoracic region)
0.002 0.998 0.000
M43.92 Deforming dorsopathy, unspecified (Cervical region)
0.002 0.998 0.000
M43.91 Deforming dorsopathy, unspecified (Occipito-atlanto-axial region)
0.002 0.998 0.000
M43.90 Deforming dorsopathy, unspecified (Multiple sites in spine)
0.002 0.998 0.000
F20.8 Other schizophrenia
0.000 0.998 0.002
M43.99 Deforming dorsopathy, unspecified (Site unspecified)
0.002 0.998 0.000
M40.52 Lordosis, unspecified (Cervical region)
0.002 0.998 0.000
F40.8 Other phobic anxiety disorders
0.002 0.998 0.000
H02.0 Entropion and trichiasis of eyelid
0.002 0.998 0.000
J11.1 Influenza with other respiratory manifestations, virus not identified
0.002 0.998 0.000
B44.1 Other pulmonary aspergillosis
0.002 0.998 0.000
F40.9 Phobic anxiety disorder, unspecified
0.002 0.998 0.000
Z89.6 Acquired absence of leg above knee
0.000 0.998 0.002
M67.2 Synovial hypertrophy, not elsewhere classified
0.002 0.998 0.000
M40.25 Other and unspecified kyphosis (Thoracolumbar region)
0.002 0.998 0.000
M40.4 Other lordosis
0.002 0.998 0.000
M40.3 Flatback syndrome
0.002 0.998 0.000
M40.0 Postural kyphosis
0.002 0.998 0.000
M46.40 Discitis, unspecified (Multiple sites in spine)
0.000 0.998 0.002
J16.8 Pneumonia due to other specified infectious organisms
0.002 0.998 0.000
M40.24 Other and unspecified kyphosis (Thoracic region)
0.002 0.998 0.000
M40.59 Lordosis, unspecified (Site unspecified)
0.002 0.998 0.000
M40.58 Lordosis, unspecified (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M40.57 Lordosis, unspecified (Lumbosacral region)
0.002 0.998 0.000
M40.55 Lordosis, unspecified (Thoracolumbar region)
0.002 0.998 0.000
M40.54 Lordosis, unspecified (Thoracic region)
0.002 0.998 0.000
M40.53 Lordosis, unspecified (Cervicothoracic region)
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.